Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Haleon PLC ( (GB:HLN) ) has shared an announcement.
Haleon PLC announced the release of its Q3 trading statement for 2025, highlighting its financial performance and strategic initiatives. The statement is accessible on the company’s website and through the Financial Conduct Authority’s National Storage Mechanism. A presentation for analysts and shareholders, led by CFO Dawn Allen, will provide further insights into the company’s operations and future outlook, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (GB:HLN) stock is a Hold with a £3.80 price target. To see the full list of analyst forecasts on Haleon PLC stock, see the GB:HLN Stock Forecast page.
Spark’s Take on GB:HLN Stock
According to Spark, TipRanks’ AI Analyst, GB:HLN is a Outperform.
Haleon PLC’s overall stock score reflects a strong financial foundation with robust profitability and cash flow management. However, technical indicators and valuation suggest a more cautious outlook. The earnings call highlighted regional strengths but also significant challenges in North America, impacting the overall sentiment. The absence of notable corporate events leaves the focus on financial and operational performance.
To see Spark’s full report on GB:HLN stock, click here.
More about Haleon PLC
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company offers a diverse product portfolio across six major categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Its well-known brands include Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren, which are grounded in trusted science and innovation.
Average Trading Volume: 20,837,748
Technical Sentiment Signal: Sell
Current Market Cap: £30.72B
See more data about HLN stock on TipRanks’ Stock Analysis page.